C07D 295/192
From aromatic carboxylic acids
Official title: from aromatic carboxylic acids
C07D295/192 (From aromatic carboxylic acids) appears on 854 US grants and 829 published applications in this corpus.
Search patents in C07D- Granted patents
- 854
- Published applications
- 829
- Assignees
- 493
- Inventors
- 2,926
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 5 | 0 |
| 1978 | 8 | 0 |
| 1979 | 8 | 0 |
| 1980 | 9 | 0 |
| 1981 | 10 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 7 | 0 |
| 1985 | 5 | 0 |
| 1986 | 5 | 0 |
| 1987 | 5 | 0 |
| 1988 | 6 | 0 |
| 1989 | 7 | 0 |
| 1990 | 15 | 0 |
| 1991 | 9 | 0 |
| 1992 | 9 | 0 |
| 1993 | 11 | 0 |
| 1994 | 9 | 0 |
| 1995 | 12 | 0 |
| 1996 | 13 | 0 |
| 1997 | 17 | 0 |
| 1998 | 23 | 0 |
| 1999 | 24 | 0 |
| 2000 | 13 | 0 |
| 2001 | 22 | 12 |
| 2002 | 34 | 34 |
| 2003 | 30 | 44 |
| 2004 | 22 | 42 |
| 2005 | 20 | 37 |
| 2006 | 18 | 37 |
| 2007 | 17 | 35 |
| 2008 | 21 | 39 |
| 2009 | 19 | 38 |
| 2010 | 24 | 39 |
| 2011 | 26 | 24 |
| 2012 | 29 | 40 |
| 2013 | 20 | 39 |
| 2014 | 36 | 46 |
| 2015 | 41 | 37 |
| 2016 | 41 | 46 |
| 2017 | 42 | 38 |
| 2018 | 17 | 28 |
| 2019 | 24 | 30 |
| 2020 | 18 | 28 |
| 2021 | 19 | 29 |
| 2022 | 23 | 26 |
| 2023 | 14 | 18 |
| 2024 | 15 | 19 |
| 2025 | 14 | 16 |
| 2026 | 9 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications11 Aug 2026US 12,703,679 B2Cura Therapeutics, LLC
- Modulators of hemoglobin9 Jun 2026US 12,649,719 B2Global Blood Therapeutics, Inc.
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium9 Jun 2026US 12,649,824 B2Resonac Corporation
- Inhibitors of the RAS oncoprotein, methods of making and methods of use thereof24 Mar 2026US 12,582,660 B2University of Louisville Research Foundation, Inc.
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
- Inhibitors of the ras oncoprotein, methods of making and methods of use thereof13 Aug 2026US 2026/0232689 A1University of Louisville Research Foundation, Inc.
- Therapeutic compounds and compositions13 Aug 2026US 2026/0234110 A1Agios Pharmaceuticals, Inc.
- Pgdh inhibitors and methods of making and using13 Aug 2026US 2026/0234142 A1Myoforte Therapeutics, Inc.
- Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same7 May 2026US 2026/0125390 A1
Most cited
By later US patents
- Inhibitors of farnesyl-protein transferase204US 5,856,326 AMerck & Co., Inc. · 1999
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Compounds and compositions for delivering active agents116US 5,773,647 AEmisphere Technologies, Inc. · 1998
- Aromatic benzamido compounds, their preparation and their use in human or veterinary medicine or in cosmetic preparations109US 4,927,928 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1990
- Stable amido peroxycarboxylic acids for bleaching91US 5,268,003 ALever Brothers Company, Division of Conopco, Inc. · 1993